EP 3442532 A1 20190220 - TREATMENT OF RENAL CELL CARCINOMA WITH LENVATINIB AND EVEROLIMUS
Title (en)
TREATMENT OF RENAL CELL CARCINOMA WITH LENVATINIB AND EVEROLIMUS
Title (de)
BEHANDLUNG EINES NIERENZELLKARZINOMS MIT LENVATINIB UND EVEROLIMUS
Title (fr)
TRAITEMENT DU CARCINOME À CELLULES RÉNALES À L'AIDE DE LENVATINIB ET D'ÉVÉROLIMUS
Publication
Application
Priority
- JP 2016081787 A 20160415
- US 201662322916 P 20160415
- JP 2017015461 W 20170417
Abstract (en)
[origin: WO2017179739A1] Methods and compositions for treating a renal cell carcinoma with the combination of lenvatinib or a pharmaceutically acceptable salt thereof and everolimus are provided. Particularly useful dosages and dose modifications upon the occurrence of adverse events are also provided.
IPC 8 full level
A61K 31/47 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/436 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP KR)
A61K 9/0053 (2013.01 - KR); A61K 31/436 (2013.01 - EP KR); A61K 31/47 (2013.01 - EP KR); A61K 45/06 (2013.01 - EP KR); A61P 35/00 (2017.12 - EP KR); A61K 2300/00 (2013.01 - KR)
C-Set (source: EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017179739 A1 20171019; AU 2017249459 A1 20181025; CA 3019682 A1 20171019; CN 108883106 A 20181123; EP 3442532 A1 20190220; EP 3442532 A4 20191211; KR 20180129795 A 20181205; SG 11201808774R A 20181129
DOCDB simple family (application)
JP 2017015461 W 20170417; AU 2017249459 A 20170417; CA 3019682 A 20170417; CN 201780020786 A 20170417; EP 17782552 A 20170417; KR 20187028053 A 20170417; SG 11201808774R A 20170417